Millennium Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Millennium Management LLC
CRD #158117
SEC #801-73884
CIK #0001426821, 0001605917, 0001273087, 0001446830
AUM 720.85 B (2026-03-31)
Employees 6,670 (46% Investors, 0% Brokers)
Fees
Minimum
Phone212-841-4100
Address399 Park Avenue
New York, NY 10022
Source [IAPD] [EDGAR] [Website] [LinkedIn] [Instagram]
Total AUM ($B)
80064048032016002010201520212027
In the News
Fri, 24 Jul 2026 Millennium Management LLC Reduces Stake in Tenax Therapeutics Inc — GuruFocus
Fri, 24 Jul 2026 Millennium Management LLC Reduces Stake in Contineum Therapeutics Inc — GuruFocus
Wed, 22 Jul 2026 Millennium Management LLC Reduces Stake in Bleichroeder Acquisition Corp II — GuruFocus
Fri, 17 Jul 2026 Millennium Management LLC Reduces Stake in Elme Communities — GuruFocus
Fri, 17 Jul 2026 Millennium Management LLC Reduces Stake in Byrna Technologies Inc — GuruFocus
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
Item 5 Fees and Compensation

Funds

The fees, expenses and/or allocations associated with an investment in a Fund vary, depending on the specific Fund,
and are detailed in the Fund’s offering document. Any applicable fees, expenses and/or allocations are deducted from
a Fund investor’s assets as described in such Fund’s offering document.

Performance-based allocations or fees are generally allocated or paid, respectively, annually and upon an investor’s
withdrawal or redemption from the applicable Fund. In the case of one Millennium Partners Fund, asset-based fees
are paid quarterly in advance and are generally subject to proration for (i) a subscription that does not fall on the first
day of a quarter or (ii) a withdrawal or redemption that does not fall on the last day of a quarter.

Millennium Partners, L.P. (“Millennium Partners”) and its Feeder Funds (together with Millennium Partners as the
context may require, the “Millennium Partners Funds”)

The Millennium Partners Funds generally bear, directly or indirectly, all expenses incurred in connection with the
operation of the Millennium Partners Funds, without limitation (which are therefore borne by the investors in the
Millennium Partners Funds), other than as described in Item 11 under “Portfolio Manager Investment in Own
Strategies.” We generally refer to this as an “expense pass-through.” Each Millennium Partners Fund also pays us a
performance-based allocation and/or an asset-based fee, and is generally responsible for:

                 a generally pro rata portion of all of the fees and expenses that such Millennium Partners Fund and
                  its affiliates incur (which include, among other things, the salaries, fringe benefits, bonuses, fees and
                  performance-based compensation (collectively, “compensation”) and expenses paid or reimbursed
                  to Portfolio Managers (as defined in Item 8 of this Brochure), other employees, consultants,
                  subcontractors and agents, fees paid to persons or entities who assist in identifying and recruiting
                  Portfolio Managers, expenses related to computers and other equipment and expenses related to
                  maintaining offices, including leases and fixtures); and

                 all fees and expenses incurred in connection with any transactions, engagements, and other
                  agreements that such Millennium Partners Fund enters into on its own behalf, including, among
                  other things, costs and expenses of its administrator, expenses incurred in connection with the private
                  placement of interests (other than placement fees), and, with respect to non-U.S. Millennium
                  Partners Funds, directors’ fees and expenses.

         Millennium Partners Funds in the aggregate bear all of the compensation paid to the Portfolio Managers
         (including Portfolio Managers that are Relying Advisers) and other employees of, and consultants to, the
         Firm and its affiliates. The compensation expenses also include management or “base” fees that are charged
         by certain Portfolio Managers or third-party funds. In addition, certain personnel who assist in overseeing
         groups of Portfolio Managers (e.g., the head of a particular strategy) receive compensation based on the
         overall performance of such Portfolio Managers. This compensation of Portfolio Managers and such
         personnel responsible for overseeing Portfolio Managers (as well as other Millennium employees) is separate
         from and in addition to the performance- and/or asset-based compensation we receive from the Millennium
         Partners Funds, which compensates us for services provided by our principal. Such expense is deducted prior
         to calculation of the performance- and/or asset-based compensation we receive from the Millennium Partners
         Funds. Compensation of a Portfolio Manager is generally determined as a percentage of profits earned by
         such Portfolio Manager during the preceding calendar year, with profits measured on an accrual (i.e., mark-
         to-market) basis and without taking into account the performance of other Portfolio Managers or of the
         Millennium Partners Funds generally. If a Portfolio Manager suffers net losses during the year, generally the
         losses are carried forward and past losses must be made up before performance-based compensation becomes
         payable in subsequent years. Portfolio Managers also receive a salary, which is generally treated as an
         advance against their performance-based compensation if there are profits (although, for certain Portfolio
         Managers, salary is instead treated as an expense of their respective accounts). There is generally no
         “carryback” or “clawback” of losses to permit recouping of performance-based compensation from prior
         years. Portfolio Managers with positive performance will receive performance-based compensation even if

        the Millennium Partners Funds’ overall returns are negative. We have agreed, and may in the future agree,
        to “guarantee” a level of compensation for a Portfolio Manager or other personnel for a particular year (or
        years) or to replace compensation that a Portfolio Manager or other personnel has forfeited in connection with
        the termination of prior employment. We have from time to time in the past negotiated, and may in the future
        negotiate, different compensation arrangements with Portfolio Managers and other personnel than those
        described above.

        In addition to the expenses listed above, the expenses of the Millennium Partners Funds, which are paid
        directly or indirectly by such Millennium Partners Funds, include all expenses directly or indirectly related
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
Item 7 Types of Clients

We manage private funds, and certain Relying Advisors have entered into separately managed account agreements to
provide discretionary investment advisory services to certain institutional investors. In the future, we may provide
investment advice to other clients, including other funds and separately managed accounts.

We require Separate Account Clients to enter into a written investment management agreement. Minimum account
sizes will vary and we may waive any account minimum.
Sector Form 13F Holdings Value ($B)
Nvidia Corp 7.3
Apple Inc 4.7
Microsoft Corp 4.6
Facebook Inc 4.1
Amazon Com Inc 3.8
Tesla Motors Inc 3.1
Alphabet Inc 3.0
Broadcom Inc 2.1
Alphabet Inc 1.8
Advanced Micro Devices Inc 1.7
View All
Holdings by Sector ($B)
2502001501005002011201620212027
Type Form D Funds Date Sold AUM
HF WMA Systematic Alpha Broad US Equity Return Master Fund LP [2026-02-03] 43.4 M
Filed 2026-01-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA US Large Cap Enhanced Equity Master Fund LP [2026-02-03] 299.1 M
Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA International Ex-US Ex-HK Active Extension Master Fund LP [2025-09-30] 1,286.9 M
Filed 2025-08-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA US Active Extension Master Fund LP [2025-08-14] 2,752.4 M
Filed 2025-05-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA Global Large Cap Enhanced Equity Master Fund LP [2025-02-05] 378.3 M
Filed 2024-10-31 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA AE Institutional Fund I LP [2023-11-27] 400.5 M 917.6 M
Filed 2025-07-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA Systematic Equity Alpha Long/Short Master Fund LP [2023-02-27] 528.7 M 3,218.5 M
Filed 2025-05-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA International Equity 130/30 Master Fund LP [2019-02-20] 454.4 M 0.1 M
Filed 2020-12-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMA US Equity 130/30 Master Fund LP [2019-02-20] 636.0 M 546.9 M
Filed 2021-12-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF WMQS Global Equity Active Extension Master Fund LP [2018-08-24] 1,277.9 M 12.76 B
Filed 2025-04-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 27 709.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 1.3
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 10.3
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 35 720.8
By Discretionary
Discretionary 35 720.8
Non-Discretionary 0 0.0
Total 35 720.8
By Non-United States Persons
Non-United States Persons 661.3
United States Persons 59.5
Total 35 720.8
Form D Directors Role # Filings # Firms 2011 - 2026
Ebony Myles-Berry Director 93 36
Ian Goodall Director 141 33
Michael McDonald Director 123 30
Robert Williams Executive Officer 30 3
Michael Gelband Executive Officer 9 3
Kevin Byrne Executive Officer 6 3
David Nolan Executive Officer 19 2
Israel Englander Executive Officer, Promoter 13 2
Simon Lorne Executive Officer 8 2
Igor Tulchinsky Promoter 8 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001273087]
3 [0001273087]
4 [0001273087]
SC 13G [0001273087]
13F-NT [0001426821]
3 [0001426821]
4 [0001426821]
3 [0001446830]
4 [0001446830]
D [0001605917]
Form 13D/13G Filer Form 13D/13G Subject Filed
Millennium Management LLC Perspective Therapeutics Inc [2026-07-20]
Millennium Management LLC Ares Acquisition Corp III [2026-07-07]
Millennium Management LLC Perspective Therapeutics Inc [2026-06-30]
Millennium Management LLC Maravai Lifesciences Holdings Inc [2026-06-29]
Millennium Management LLC Bellring Brands Inc [2026-06-29]
Millennium Management LLC Lenz Therapeutics Inc [2026-06-26]
Millennium Management LLC Xanadu Quantum Technologies Ltd [2026-06-25]
Millennium Management LLC DXC Technology Co [2026-06-24]
Millennium Management LLC Maravai Lifesciences Holdings Inc [2026-06-23]
Millennium Management LLC Relmada Therapeutics Inc [2026-06-22]
View All
Firm Profile (Form ADV)
Discretionary AUM$156.7B
ServesInstitutional
Fund TypesHedge Fund
LEI549300D0DN3CHSCJ0I36
Form 3/4/5 Subject 2011 - 2026
Faeth Therapeutics Inc
Englander Israel A
Millennium Management LLC
ICS Opportunities II LLC
Millennium Group Management LLC
CXApp Inc
ICS Opportunities Ltd
FiscalNote Holdings Inc
Megalith Financial Acquisition Corp
Integrated Core Strategies US LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
CXApp Inc CXAI
Class A Common Stock
2022-12-28 Other 175,000 $10.12 1,771,000
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
2021-12-17 Sell 300,000 $9.87 2,961,000
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
2021-11-12 Buy 30,681 $9.92 304,356
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
2021-11-08 Buy 54,773 $9.92 543,348
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 209,699 $10.45 2,191,355
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 91 $10.50 956
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 189 $10.52 1,988
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
2020-06-03 Sell 21 $10.55 222
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-17 Sell 216,200 $3.65 789,130
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-13 Sell 100,000 $3.71 371,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-13 Sell 100,000 $3.65 365,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-12 Sell 100,000 $3.58 358,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-11 Sell 100,000 $3.50 350,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-06 Sell 75,000 $3.53 264,750
Liberator Medical Holdings Inc LBMH
Common Stock
2015-02-05 Sell 100,000 $3.35 335,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-01-30 Sell 75,000 $3.27 245,250
Liberator Medical Holdings Inc LBMH
Common Stock
2015-01-28 Sell 100,000 $3.17 317,000
Liberator Medical Holdings Inc LBMH
Common Stock
2015-01-15 Sell 50,000 $3.15 157,500
Liberator Medical Holdings Inc LBMH
Common Stock
2014-06-27 Sell 100,000 $4.00 400,000
Liberator Medical Holdings Inc LBMH
Common Stock
2014-06-24 Sell 175,000 $4.05 708,750
showing 20 of 38 most recent transactions
Comparable Firms State AUM
BlackRock Advisors LLC
NY 1,096.12 B
Nomura Asset Management Co Ltd
601.79 B
Massachusetts Financial Services Company
MA 514.05 B
Arrowstreet Capital Limited Partnership
MA 351.32 B
Legal & General Investment Management America Inc
IL 267.16 B
Amova Asset Management Co Ltd
247.43 B
Two Sigma Investments LP
NY 232.82 B
Squarepoint Ops LLC
NY 226.98 B
Schonfeld Strategic Advisors LLC
NY 225.25 B
Rokos Capital Management LLP
219.44 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com